← Library
GHRP-2
Research Use
Also known as Pralmorelin, KP102
Function
Primary
GH deficiency testing · Body composition
Secondary
Anti-aging
Mechanism
Ghrelin / GHS-R1a agonist — potent GH release; used in diagnostic GH stimulation tests; raises IGF-1; appetite stimulation.
Evidence
Pre-clinical / Observational
Research
Phase I/II; approved diagnostically in Japan
Dosing
Range
100–300 mcg/dose
Frequency
1–3× daily
Route
Subcutaneous
Cycling
8–12 weeks on / 4 weeks off.
Benefits
- ·Strong GH pulse
- ·Useful diagnostic tool
- ·Body composition support (off-label)
Risks
- ·Cortisol and prolactin elevation
- ·Strong appetite stimulation
- ·Desensitization
Contraindications
- ·Active malignancy
- ·Pregnancy
Regulatory
Diagnostic agent approved in Japan; not FDA-approved
Functional Groups
Cited Works
- Bowers CY. GH releasing peptides — clinical use. J Clin Endocrinol Metab. 1996;81:1577.source